[
  {
    "ts": null,
    "headline": "This 12 Dividend Stock Portfolio Will Pay Your Bills – Every Week",
    "summary": "Most dividend stocks pay quarterly—but your bills don’t. Rent, groceries, gas, surprise car repairs… life doesn’t come once every three months. That’s why some investors are building what’s called a Weekly Paycheck Portfolio—a curated list of dividend-paying stocks staggered to deliver consistent income every week of the year. With the right mix of stocks across […]",
    "url": "https://finnhub.io/api/news?id=db54078f4040b6a9e482ab7dff995d522883338088e53fcd73ef0db932611d21",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753117446,
      "headline": "This 12 Dividend Stock Portfolio Will Pay Your Bills – Every Week",
      "id": 136031297,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Most dividend stocks pay quarterly—but your bills don’t. Rent, groceries, gas, surprise car repairs… life doesn’t come once every three months. That’s why some investors are building what’s called a Weekly Paycheck Portfolio—a curated list of dividend-paying stocks staggered to deliver consistent income every week of the year. With the right mix of stocks across […]",
      "url": "https://finnhub.io/api/news?id=db54078f4040b6a9e482ab7dff995d522883338088e53fcd73ef0db932611d21"
    }
  },
  {
    "ts": null,
    "headline": "[Latest] Global Cardiac Tissue Engineering Market Size/Share Worth USD 2,943.92 Million by 2034 at a 16.65% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
    "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Cardiac Tissue Engineering Market size & share revenue was valued at approximately USD 632.10 Million in 2024 and is expected to reach USD 735.98 Million in 2025 and is expected to reach around USD 2,943.92 Million by 2034, at a CAGR of 16.65% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Abbott Labor",
    "url": "https://finnhub.io/api/news?id=0a6c28a35cbbb6f1d320ee175862c370baa6af8eae4ccaecd54ba43285e64341",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753115400,
      "headline": "[Latest] Global Cardiac Tissue Engineering Market Size/Share Worth USD 2,943.92 Million by 2034 at a 16.65% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
      "id": 136026979,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Cardiac Tissue Engineering Market size & share revenue was valued at approximately USD 632.10 Million in 2024 and is expected to reach USD 735.98 Million in 2025 and is expected to reach around USD 2,943.92 Million by 2034, at a CAGR of 16.65% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Abbott Labor",
      "url": "https://finnhub.io/api/news?id=0a6c28a35cbbb6f1d320ee175862c370baa6af8eae4ccaecd54ba43285e64341"
    }
  },
  {
    "ts": null,
    "headline": "GE HealthCare Stock: Hidden Winner Of Alzheimer's Drug Boom",
    "summary": "GE HealthCare Technologies' market position, rising earnings, and improving financials make it an attractive investment opportunity. Read more on GEHC stock.",
    "url": "https://finnhub.io/api/news?id=9b754ef528fe7b96b0cce9ccb833959abb45dd40ecee9b9f814293e42b25b101",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753106894,
      "headline": "GE HealthCare Stock: Hidden Winner Of Alzheimer's Drug Boom",
      "id": 136027327,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/82190263/image_82190263.jpg?io=getty-c-w1536",
      "related": "MDT",
      "source": "SeekingAlpha",
      "summary": "GE HealthCare Technologies' market position, rising earnings, and improving financials make it an attractive investment opportunity. Read more on GEHC stock.",
      "url": "https://finnhub.io/api/news?id=9b754ef528fe7b96b0cce9ccb833959abb45dd40ecee9b9f814293e42b25b101"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic secures CE Mark for MiniMed™ 780G System for insulin-requiring people with diabetes including expanded indications in children as young as two, during pregnancy, and for type 2 diabetes",
    "summary": "Medtronic plc (NYSE: MDT), a global leader in medical technology, today announced CE (Conformité Européenne) Mark in Europe to expand indications of the MiniMed™ 780G system for use by individuals aged 2 years and older, during pregnancy, as well as type 2 insulin-requiring diabetes. To gain CE Mark for this expansion of indications, published clinical data in 2–6-year-olds, pregnant women, and people living with type 2 diabetes was reviewed. This expanded indication underscores the commitment M",
    "url": "https://finnhub.io/api/news?id=7abaae01fdf31f37a0d02856c3e7b5584a1bed56c71369893d7b2510ab070960",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753101900,
      "headline": "Medtronic secures CE Mark for MiniMed™ 780G System for insulin-requiring people with diabetes including expanded indications in children as young as two, during pregnancy, and for type 2 diabetes",
      "id": 136025688,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic plc (NYSE: MDT), a global leader in medical technology, today announced CE (Conformité Européenne) Mark in Europe to expand indications of the MiniMed™ 780G system for use by individuals aged 2 years and older, during pregnancy, as well as type 2 insulin-requiring diabetes. To gain CE Mark for this expansion of indications, published clinical data in 2–6-year-olds, pregnant women, and people living with type 2 diabetes was reviewed. This expanded indication underscores the commitment M",
      "url": "https://finnhub.io/api/news?id=7abaae01fdf31f37a0d02856c3e7b5584a1bed56c71369893d7b2510ab070960"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic’s $106m heart valve patent infringement ruling overturned",
    "summary": "In 2023, a jury found that Medtronic infringed on a patent for a heart valve replacement method developed by Colibri Heart Valve.",
    "url": "https://finnhub.io/api/news?id=7a550bf3698dc707d7ca465269f6db0156c1d88be1db309939d7252e5ebd8ae3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753097539,
      "headline": "Medtronic’s $106m heart valve patent infringement ruling overturned",
      "id": 136025689,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "In 2023, a jury found that Medtronic infringed on a patent for a heart valve replacement method developed by Colibri Heart Valve.",
      "url": "https://finnhub.io/api/news?id=7a550bf3698dc707d7ca465269f6db0156c1d88be1db309939d7252e5ebd8ae3"
    }
  }
]